A review of literature was conducted to explore nurses’ perceptions of phase I clinical trials in pediatric oncology. Specifically, nurses’ perceptions of the goals and outcomes, the nurse’s role, and the informed consent process in pediatric oncology phase I clinical trials were investigated. Findings on possible factors influencing the nurses’ perceptions and the quality of work-life of nurses working at pediatric phase I clinical trial centers were also searched. However, despite an extensive review of published works, no studies on nurses’ perceptions of phase I trials in pediatric oncology were found. Therefore, this literature review consists of findings in similar or related studies such as nurses’ perceptions of experimental therapies in the adult setting, adult patients’ perceptions, parents’ perceptions, or oncologists’perceptions of phase I clinical trials.
American Society of Clinical Oncology. (1997). Critical role of phase I clinical trials in cancer treatment. Journal of Clinical Oncology, 15(2), 853-859.
2.
Berry, D. L., Dodd, M. J., Hinds, P. S., & Ferrell, B. R. (1996). Ethical issues. Informed consent: Process and clinical issues. Oncology Nursing Forum, 23(3), 507-512.
3.
Bleyer, W. A. (1997). The U.S. pediatric cancer clinical trials programmes: International implication and the way forward. European Journal of Cancer, 33(9), 1439-1447.
4.
Bujorian, G. (1988). Clinical trial: Patient issues in the decision-making process. Oncology Nursing Forum, 15(6), 779-782.
5.
Burnett, C. B., Koczwara, B., Pixley, L, Blumenson, L. E., Hwang, Y. T., & Meropol, N. J. (2001). Nurses’ attitudes toward clinical trials at a comprehensive cancer center. Oncology Nursing Forum, 28(7), 1187-1192.
6.
Cassidy, J., & Macfarlane, D. K. (1991). The role of the nurse in clinical cancer research. Cancer Nursing, 14(3), 124-131.
7.
Cheng, J. D., Hitt, J., Koczwara, B., Schulman, K. A., Burnett, C. B., Gaskin, D. J., et al. (2000). Impact of quality of life on patient expectations regarding phase I clinical trials. Journal of Clinical Oncology, 18(2), 421-428.
8.
Cogliano-Shutta, N. A. (1986). Pediatric phase I clinical trials: ethical issues and nursing considerations. Oncology Nursing Forum, 13(2), 29-32.
9.
Daugherty, C., Ratain, M. J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., et al. (1995). Perceptions of cancer patients and their physicians involved in phase I clinical trials. Journal of Clinical Oncology, 13(5), 1062-1072.
10.
Daugherty, C. K. (1999). Impact of therapeutic research on informed consent and the ethics of clinical trials: A medical oncology perspective. Journal of Clinical Oncology, 17(5), 1601-1617.
11.
Deatrick, J. A., Angst, D. B., & Moore, C. (2002). Parents’ views of their children’s participation in phase I oncology clinical trials. Journal of Pediatric Oncology Nursing, 19(4), 114-121.
12.
Decoster, G., Stein, G., & Holdener, E. E. (1990). Responses and toxic deaths in phase I clinical Trials. Annals of Oncology, 1(3), 175-181.
13.
Elkind, A. K. (1982). Nurses’ views about cancer. Journal of Advanced Nursing, 7, 43-50.
14.
Engelking, C. (1991). Facilitating clinical trials. The expanding role of the nurse. Cancer, 67(Suppl. 6), 1793-1797.
15.
Estlin, E. J., Cotterill, S., Pratt, C. B., Pearson, A. D. J., & Bernstein, M. (2000). Phase I trials in pediatric oncology: Perceptions of pediatricians from the United Kingdom Children’s Cancer Group and the Pediatric Oncology Group. Journal of Clinical Oncology, 18(9), 1900-1905.
16.
Fallowfield, L., Ratcliffe, D., & Souhami, R. (1997). Clinician’s attitudes to clinical trials of cancer therapy. European Journal of Cancer, 33(13), 2221-2229.
17.
Fochtman, D., & Hinds, P. S. (2000). Identifying nursing research priorities in a pediatric clinical trials cooperative group: The pediatric oncology group experience. Journal of Pediatric Oncology Nursing, 17(2), 83-87.
18.
Furman, W. L., Pratt, C. B., Rivera, G. K., Krischer, J. P., Kamen, B. A., & Vietti, T. J. (1989). Mortality in pediatric phase I clinical trials. Journal of the National Cancer Institute, 81(15), 1193-1194.
19.
Grady, C. (1991). Ethical issues in clinical trials. Seminars in Oncology Nursing, 7(4), 288-296.
20.
Grossman, S. A, Piantadosi, S., & Covahey, C. (1994). Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families?Journal of Clinical Oncology, 12(10), 2211-2215.
21.
Hazelton, J. (1991). The role of the nurse in phase I clinical trials. Journal of Pediatric Oncology Nursing, 8(1), 43-45.
22.
Hinds, P. S., Gilger, E. A., Eder, M., & Kodish, E. (2002). The nurse as witness in the research consent/assent process: An inherently problematic role, or an ethical obligation?Journal of Pediatric Oncology Nursing, 19(1), 35-40.
23.
Hinds, P. S., Oakes, L., Furman, W., Foppiano, P., Olson, M. S., Quargnenti, A., et al. (1997). Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancer. Oncology Nursing Forum, 24(9), 1523-1528.
24.
Hubbard, S. M. (1982). Cancer treatment research: The role of the nurse in clinical trials of cancer therapy. Nursing Clinics of North America, 17(4), 763-783.
25.
Hutchison, C. (1998). Phase I trials in cancer patients: Participants’ perceptions. European Journal of Cancer Care, 7(1), 15-22.
26.
Kamps, W. A., Akkerboom, J. C., Kingma, A., & Humphrey, G. B. (1987). Experimental chemotherapy in children with cancer—A parent’s view. Pediatric Hematology & Oncology, 4(2), 117-124.
27.
Kamps, W. A., Akkerboom, J. C., Nitschke, R., Kingma, A., Holmes, H. B., Caldwell, S., et al. (1987). Altruism and informed consent in chemotherapy trials in childhood cancer. Loss, Grief, & Care, 1(3-4), 93-110.
28.
Kodish, E., Stocking, C., Ratain, M. J., Kohrman, A., & Siegler, M. (1992). Ethical issues in phase I oncology research: A comparison of investigators and Institutional Review Board chairpersons. Journal of Clinical Oncology, 10(11), 1810-1816.
29.
Krishnasamy, M. (1999). Nursing, morality, and emotions: Phase I and phase II clinical trials and patients with cancer. Cancer Nursing, 22(4), 251-259.
30.
Leventhal, B. G., & Graham, M. L. (1988). Clinical trials in pediatric oncology. Seminars in Oncology, 15(5), 482-487.
31.
Lind, S. E., DelVecchio Good, M. J., Minkovitz, C. S., & Good, B. J. (1991). Oncologists vary in their willingness to undertake anti-cancer therapies. British Journal of Cancer, 64(2), 391-395.
32.
MacArthur, C. A., & Vietti, T. (1996). The importance of phase I/II trials in pediatric oncology. Investigational New Drugs, 14(1), 33-35.
33.
McEvoy, M. D., Cannon, L., & MacDermott, M. L. (1991). The professional role for nurses in clinical trials. Seminars in Oncology Nursing, 7(4), 268-274.
34.
Melink, T. J. (1989). Phase I trials: Role of the nurse investigator. Cancer Treatment and Research, 42, 105-124.
35.
Melink, T. J., Clark, G. M., & Von Hoff, D. D. (1992). The impact of phase I clinical trials on the quality of life in patients with cancer. Anticancer Drugs, 3(6), 571-576.
36.
Penman, D. T., Holland, J. C., Bahna, G. F., Morrow, G., Schmale, A. J., Derogatis, L. R., et al. (1984). Informed consent for investigational therapy: Patients’ and physicians’ perceptions. Journal of Clinical Oncology, 2(7), 849-855.
37.
Pratt, C. B. (1991). The conduct of phase I-II clinical trials in children with cancer. Medical & Pediatric Oncology, 19(4), 304-309.
38.
Rosse, P. A., & Krebs, L. U. (1999). The nurse’s role in the informed consent process. Seminars in Oncology Nursing, 15(2), 116-123.
39.
Ruccione, K., & Kelly, K. P. (2000). Pediatric oncology nursing in cooperative group clinical trials comes of age. Seminars in Oncology Nursing, 16(4), 253-260.
40.
Schutta, K. M., & Burnett, C. B. (2000). Factors that influence a patient’s decision to participate in a phase I cancer clinical trial. Oncology Nursing Forum, 27(9), 1435-1438.
41.
Simon, C., Eder, M., Raiz, P., Zyzanski, S., Pentz, R., & Kodish, E. D. (2001). Informed consent for pediatric leukemia research: Clinician perspectives. Cancer, 92(3), 691-700.
42.
Slevin, M., Mossman, J., Bowling, A., Leonard, R., Steward, W., Harper, P., et al. (1995). Volunteers or victims: Patients’ view of randomized cancer clinical trials. British Journal of Cancer, 71(6), 1270-1274.
43.
Smith, M., Bernstein, M., Bleyer, W. A., Borsi, J. D., Ho, P., Lewis, I. J., et al. (1998). Conduct of phase I trials in children with cancer. Journal of Clinical Oncology, 16(3), 966-978.
44.
Tarnowski, K. J., Alen, D. M., Mayhall, C., & Kelly, P. A. (1990). Readability of pediatric biomedical research informed consent forms. Pediatrics, 85(1), 58-62.
45.
Von Hoff, D. D., & Turner, J. (1991). Response rates, duration of response, and dose response effects in phase I studies of anti-neoplastics. Investigational New Drugs, 9(1), 115-122.
46.
Yoder, L. J., O’Rourke, T. J., Etnyre, A., Spears, D. T., & Brown, T. D. (1997). Expectations and experiences of patients with cancer participating in phase I clinical trials. Oncology Nursing Forum, 24(5), 891-896.
